InvestorsHub Logo
icon url

rahrah

01/22/23 1:32 PM

#5271 RE: DewDiligence #5268

Yes, probable decline in COVID vaccine sales, but PFE will potentially get FDA approval for RSV vaccine in May, and they are the only one targeting both adult and child RSV.
icon url

DewDiligence

02/06/23 8:53 PM

#5360 RE: DewDiligence #5268

Barron’s cover story—>bullish on PFE—and it doesn’t even mention the ~$10B of HLN equity that PFE can monetize at any time:

https://www.barrons.com/articles/buy-pfizer-stock-price-pick-covid-51675469303